Teradyne, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$293.75M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TER stock price vs QRVO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at QRVO's multiple
Needs QRVO P/E.
Implied fair value · at TER's multiple
Needs TER P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TERADYNE, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Qorvo, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
APPLIED MATERIALS INC /DE
TER vs AMAT
INTEL CORP
TER vs INTC
LAM RESEARCH CORP
TER vs LRCX
KLA CORP
TER vs KLAC
SKYWORKS SOLUTIONS, INC.
TER vs SWKS
LATTICE SEMICONDUCTOR CORP
TER vs LSCC
Broadcom Inc.
TER vs AVGO
Marvell Technology, Inc.
TER vs MRVL
ON SEMICONDUCTOR CORP
TER vs ON
NXP Semiconductors N.V.
TER vs NXPI
TEXAS INSTRUMENTS INC
TER vs TXN
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TER can sustain its 13.1% revenue growth and 27.5% ROIC long enough to justify a very large premium multiple, then hold or avoid selling aggressively because the fundamentals are much stronger than QRVO's; otherwise, the valuation gap versus the $91.38 P/E implied value and the $32.22-$43.60 DCF range argues for caution.
TER trades at a major premium to QRVO on every listed valuation metric, with P/E at 110.9x versus 26.3x and EV/EBITDA at 77.6x versus 11.3x. Despite stronger operating metrics, the current price of $384.89 sits well above QRVO implied range and far above the DCF range.
Supporting Metrics